Pulmatrix Inc PULM:NASDAQ

RT Quote | NASDAQ | USD
Last | 4:00 PM EDT
4.52quote price arrow down-0.07 (-1.53%)
Volume
4,726
52 week range
4.03 - 21.20
Loading...
  • Open4.52
  • Day High4.86
  • Day Low4.52
  • Prev Close4.59
  • 52 Week High21.20
  • 52 Week High Date07/01/21
  • 52 Week Low4.03
  • 52 Week Low Date06/16/22

Key Stats

  • Market Cap15.32M
  • Shares Out3.39M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta1.12
  • YTD % Change-44.47

KEY STATS

  • Open4.52
  • Day High4.86
  • Day Low4.52
  • Prev Close4.59
  • 52 Week High21.20
  • 52 Week High Date07/01/21
  • 52 Week Low4.03
  • 52 Week Low Date06/16/22
  • Market Cap15.32M
  • Shares Out3.39M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta1.12
  • YTD % Change-44.47

RATIOS/PROFITABILITY

  • EPS (TTM)-8.31
  • P/E (TTM)-0.54
  • Fwd P/E (NTM)-1.00
  • EBITDA (TTM)-17.315M
  • ROE (TTM)-49.03%
  • Revenue (TTM)4.94M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-426.00%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date08/08/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Pulmatrix Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Pulmatrix, Inc. is a clinical-stage biotechnology company, which is focused on the discovery and development of inhaled therapeutic products to prevent and treat respiratory and other diseases with unmet medical needs. It designs and develops inhaled therapeutic products based on its dry powder delivery technology, inhaled small particles easily respirable and emitted (iSPERSE), which enables delivery of small or large molecule drugs to the lungs by inhalation for local or...
Michael Higgins
Independent Chairman of the Board
Teofilo Raad
President, Chief Executive Officer, Director
Peter Ludlum CPA
Interim Chief Financial Officer
Michelle Siegert
Vice President - Finance
Address
99 Hayden Ave Ste 390
Lexington, MA
02421-7966
United States